Ethic Inc’s Lexicon Pharmaceuticals LXRX Stock Holding History

Ethic Inc’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,259	Closed	-$8.01K	–	1269
2025 Q1	$8.01K	Buy	+17,259	New	+$10.9K	﹤0.01%	1162

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ethic Inc's LXRX Position: Q2 2025 in Review

Ethic Inc sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2025, closing a stake of 17,259 shares — an estimated $8.01K sold.

Ethic Inc first reported a position in LXRX in Q1 2025 and held it in 1 quarter. The position peaked at $8.01K in Q1 2025. 123 funds tracked by Wall St. Rank hold LXRX as of Q2 2025.

Ethic Inc reported no remaining Lexicon Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Ethic Inc sold 17,259 Lexicon Pharmaceuticals shares in Q2 2025, an estimated $8.01K.
Ethic Inc first reported a position in Lexicon Pharmaceuticals in Q1 2025 and held it in 1 quarter.
Ethic Inc's Lexicon Pharmaceuticals position peaked at $8.01K in Q1 2025.
123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2025.

Based on Ethic Inc's 13F filing for Q2 2025, filed 30 Jul 2025.